Acumen Pharmaceuticals, Inc. (ABOS) Free cash flow 2021–2025
Acumen Pharmaceuticals, Inc. (ABOS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$115.6MFY2025 · since FY2021: -$18.0M → -$115.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$115.6M | -34.1% |
| FY2024 | -$86.2M | -100.1% |
| FY2023 | -$43.1M | -22.0% |
| FY2022 | -$35.3M | -96.2% |
| FY2021 | -$18.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ABOS financial trends
ABOS RevenueABOS Net incomeABOS Net marginABOS Gross profitABOS Gross marginABOS Operating incomeABOS Operating marginABOS Operating cash flowABOS Capital expendituresABOS Return on equityABOS Stock buybacksABOS Dividends paidABOS Total assetsABOS Total liabilitiesABOS Shareholders’ equityABOS overview →